Accessible Search Form           Advanced Search

Jacques Rossouw, MB.ChB., F.C.P. (S.A.), M.D.

To arrange an interview, please contact the NHLBI Communications Office at 301-496-4236 or

Portrait of Jacques Rossouw
Jacques Rossouw, MB.ChB., F.C.P. (S.A.), M.D.

High Res JPG file (400 KB)


Jacques Rossouw, MB.ChB., F.C.P. (S.A.), M.D., is chief of the Women’s Health Initiative (WHI) Branch in the Division of Cardiovascular Sciences at the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH).

Dr. Rossouw oversees the WHI, which was established by the NIH in 1991 to address the most common causes of death, disability and impaired quality of life in postmenopausal women. The WHI is comprised of a set of clinical trials and observational studies involving over 161,000 postmenopausal women investigating risk factors and testing prevention strategies for heart disease, cancers of the breast and the large bowel, and fractures due to osteoporosis in women. The WHI is one of the largest U.S. prevention studies of its kind.

Prior to joining the NHLBI in 1989, Dr. Rossouw served as the director of the National Research Institute for Nutritional Diseases of the South African Medical Research Council, where he was responsible for launching the Coronary Risk Factor Study (CORIS), a community prevention trial.

Dr. Rossouw graduated from the University of Cape Town in South Africa, where he studied internal medicine and hepatology.

Dr. Rossouw is the author or coauthor of more than 150 articles and book chapters on a variety of topics, including postmenopausal hormone therapy and cardiovascular disease, lipids, nutrition, and community intervention studies.

Areas of expertise: examination of epidemiologic and clinical trial data on postmenopausal hormone therapy, lipids and other biomarkers, and coronary heart disease

Dr. Rossouw In the News

May 5, 2014
Health and financial analysis reinforces NIH's decision to fund Women's Health Initiative
An in-depth analysis of final data from one of the Women’s Health Initiative (WHI) Postmenopausal Hormone Therapy Trials has found that the investment in WHI resulted in a return of $140 in net economic value for each dollar invested in the trial.

May 1, 2014 : The Columbus Dispatch
Huge study saved lives and closed gender gap in research
Ben Sutherly
It has been credited with preventing thousands of cases of breast cancer. It has confounded medical experts on everything from diet to hormone therapy. But the NHLBI-supported Women’s Health Initiative also has cut through some of the clutter of smaller medical studies that offer contradictory conclusions about what’s best for women’s health.

View all Dr. Rossouw in the news articles

Last Updated: April 09, 2012